Home
Who we are
Pipeline
News
Contact
ORPHELIA Pharma
is a biopharmaceutical company dedicated to the development and marketing of pediatric and orphan drugs.
Our mission is to develop essential medicines to improve
care and support of patients suffering from orphan diseases.
Latest news and reports
Latest news and report
16 June 2021
European Patent covering Kimozo®
Read more
8 June 2021
ORPHELIA Pharma recrute un coordinateur d’étude clinique
Read more
20 May 2021
ORPHELIA Pharma recrute un/une Chargé(e) Qualité
Read more
4 May 2021
Inclusion of the first patient in the TEMOkids pediatric clinical trial
Read more
26 April 2021
ORPHELIA Pharma recrute un/une Assistant(e) de direction, Office Manager
Read more
6 April 2021
License agreement for the distribution of Kigabeq® in 14 european countries
Read more
2 February 2021
Opening of the operating pharmaceutical establishment
Read more
26 January 2021
Grant obtained from the region Île-de-France to support business activity development in Europe and the United States
Read more
